In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome-Reference-Cited by-同舟云学术

In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome

Published:2011-06 Issue:2 Volume:80 Page:574-581
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhao Dawen,Chang Cheng-Hui,Kim Jae G.,Liu Hanli,Mason Ralph P.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Vascular attack as a therapeutic strategy for cancer;Denekamp;Cancer Metastasis Rev,1990

2. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies;Horsman;Cancer Res,2006

3. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature;Dark;Cancer Res,1997

4. Tumour vascular disrupting agents: Combating treatment resistance;Tozer;Br J Radiol,2008

5. Enhancement of radiation therapy by the novel vascular targeting agent ZD6126;Siemann;Int J Radiat Oncol Biol Phys,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment;Cancers;2022-08-30

2. Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment;Cancers;2021-09-24

3. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors;Cancers;2021-08-04

4. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors;Molecules;2021-04-27

5. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization–photothermal ablation treatment of hepatocellular carcinoma in rats;Cancer Imaging;2019-11-04